Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.970
-0.060 (-2.96%)
At close: Oct 22, 2026, 4:00 PM EDT
1.970
0.00 (0.00%)
Pre-market: Oct 23, 2026, 4:16 AM EDT
Seer, Inc. Revenue
Seer, Inc. had revenue of $3.10M in the quarter ending June 30, 2026, a decrease of -23.43%. This brings the company's total for the last twelve months to $14.22M, down -12.71% year-over-year. In the year 2025, Seer, Inc. had annual revenue of $16.58M with 16.99% growth. That makes Seer, Inc. the 35,658th largest company in the world by revenue and 4,692nd in the United States.
Revenue (ttm)
$14.22M
Revenue Growth
-12.71%
P/S Ratio
7.67
Revenue / Employee
$114,653
Employees
124
Market Cap
109.08M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.58M | 2.41M | 16.99% |
| Dec 31, 2024 | 14.17M | -2.49M | -14.95% |
| Dec 31, 2023 | 16.66M | 1.17M | 7.54% |
| Dec 31, 2022 | 15.49M | 8.88M | 134.14% |
| Dec 31, 2021 | 6.62M | 5.96M | 908.69% |
| Dec 31, 2020 | 656.00K | 540.00K | 465.52% |
| Dec 31, 2019 | 116.00K | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cibus | 4.35M |
| NRx Pharmaceuticals | 3.39M |
| Humacyte | 2.12M |
| Kazia Therapeutics | 1.27M |
| Genelux | 8.00K |
SEER News
- 1 day ago - Seer to Report Third Quarter 2026 Financial Results on November 10, 2026 - GlobeNewsWire
- 22 days ago - Seer, Inc. Slides: Investor presentation - Filings
- 4 weeks ago - Seer, Nanyang University to present early findings from PRECISE-SG100K study - TheFly
- 4 weeks ago - Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026 - GlobeNewsWire
- 4 weeks ago - Seer announces expected departure of Chief Financial Officer, Treasurer Seer - TheFly
- 4 weeks ago - Seer Announces CFO Transition - GlobeNewsWire
- 5 weeks ago - Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale - GlobeNewsWire
- 6 weeks ago - Radoff-JEC Group calls on Seer director Meeta Gulyani to immediately resign - TheFly